<DOC>
	<DOCNO>NCT02265367</DOCNO>
	<brief_summary>The purpose study provide preliminary information assess levomilnacipran may effective increase smoking cessation rate .</brief_summary>
	<brief_title>Novel Medication Potential Smoking Cessation Aid</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>Be 25 year old 55 year old Smoke minimum number cigarette per day Indicate motivation quit smoke Current history medical psychiatric condition could interfere measure study could affect study medication Use medication could interfere measure study could expect interact levomilnacipran Are pregnant breast feed The investigator evaluate reason someone may eligible participate</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>